Optimization of the radiosynthesis of the Alzheimer tracer 2-(4-N-[11C]methylaminophenyl)-6-hydroxybenzothiazole ([11C]PIB)

Applied Radiation and Isotopes

Volumn 69, Issue 9, 2011, Pages 1212-1217

  Philippe, C ^a,b   Haeusler, D ^a   Mitterhauser, M ^a,b,c   Ungersboeck, J ^a,b   Viernstein, H ^b   Dudczak, R ^a   Wadsak, W ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alzheimer's disease (AD); Carbon 11; Methyl triflate; PET; PIB

Indexed keywords

ALZHEIMER'S DISEASE; CARBON-11; METHYL TRIFLATES; PET; PIB;

SYNTHESIS (CHEMICAL);

PITTSBURGH COMPOUND B;

ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG PURIFICATION; DRUG PURITY; DRUG SYNTHESIS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUALITY CONTROL; RADIOACTIVITY; RADIOISOTOPE DECAY; RELIABILITY;

ALZHEIMER DISEASE; AUTOMATION, LABORATORY; BENZOTHIAZOLES; CARBON RADIOISOTOPES; HUMANS; ISOTOPE LABELING; PLAQUE, AMYLOID; RADIOPHARMACEUTICALS;

EID: 79957583926     PISSN: 09698043     EISSN: 18729800     Source Type: Journal    
DOI: 10.1016/j.apradiso.2011.04.010     Document Type: Article

References (19)

1. Carpenter A.P., Pontecorvo M.J., Hefti F.F., Skovronsky D.M. The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience. Q. J. Nucl. Med. Mol. Imaging 2009, 53:387-393.
2. Grimmer T., Henriksen G., Wester H.J., Förstl H., Klunk W.E., Mathis C.A., Kurz A., Drzezga A. Progression of cerabral amyloid is associated with the apolipoprotein Eε4 genotype in Alzheimer's disease. Neurobiol. Aging 2009, 30:1902-1909.
3. Herholz K., Carter S.F., Jones M. Positron emission tomography imaging in dementia. Br. J. Radiol. 2007, 80(Spec No 2):S160-S167.
4. Holschbach M., Schüller M. An online method fort he preparation of NCA [(CH3)-C-11]trifluoromethanesulfonic acid methyl-ester. Appl. Radiat. Isot. 1993, 44:897-898.
5. Jewett D.M. A simple synthesis of [11C]methyl triflate. Int. J. Rad. Appl. Instrum. 1992, 43:1383-1385.
6. Klunk W.E., Engler H., Nordberg A., Wang Y.M., Blomqvist G., Holt D.P., Bergstrom M., Savitcheva I., Huang G.F., Estrada S., Ausen B., Debnath M.L., Barletta J., Price J.C., Sandell J., Lopresti B.J., Wall A., Koivisto P., Antoni G., Mathis C.A., Langstrom B. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann. Neurol. 2004, 55:306-319.
7. Koole M., Lewis D.M., Buckley C., Nelissen N., Vandenbulcke M., Brooks D.J., Vandenberghe R, VanLaere K. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J. Nucl. Med. 2009, 50:818-822.
8. Larsen P., Ulin J., Dahlstrom K., Jensen M. Synthesis of [C-11]iodomethane by iodination of [C-11]methane. Appl. Radiat. Isot. 1997, 48:153-157.
9. Mathis C.A., Wang Y., Holt D.P., Huang G.-F., Debnath M.L., Klunk W.E. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 2003, 46:2740-2754.
10. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol. 2004, 3:519-527.
11. Nordberg A. Amyloid plaque imaging in vivo: current achievement and future prospects. Eur. J. Nucl. Med. Mol. 2008, 35(Suppl 1):S46-S50.
12. Rabinovici G.D., Jagust W.J. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav. Neurol. 2009, 21:117-128.
13. Radioactive pharmaceuticals (Radiopharmaceutica, 6.0/0125), 2008. In: European Pharmacopoeia (Europäisches Arzneibuch), official Austrian version, sixth ed. (6. Ausgabe), Verlag Österreich GmbH, Vienna, pp. 995-1003.
14. Roe C.M., Mintun M.A., Ghoshal N., Williams M.M., Grant E.A., Marcus D.S., Morris J.C. Alzheimer disease identification using amyloid imaging and reserve variables. Neurology 2010, 75:42-48.
15. Solbach C., Uebele M., Reischl G., Machulla H.-J. Efficient radiosynthesis of carbon-11 labelled uncharched Thioflavin T derivatives using [11C]methyl triflate for Β-amyloid imaging in Alzheimer's disease. Appl. Radiat. Isot. 2005, 62:591-595.
16. Tiraboschi P., Hansen L.A., Thal L.J., Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 2004, 62(11):1984-1989.
17. Tolboom N., van der Flier W.M., Boverhoff J., Yaqub M., Wattjes M.P., Raijmakers P.G., Barkhof F., Scheltens P., Herholz K., Lammertsma A.A., van Berckel B.N.M. Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images. J. Neurol. Neurosurg. Psychiatry 2010, 81:882-884.
18. Wilson A.A., Garcia A., Chestakova A., Kung H., Houle S.J. A rapid one-step radiosynthesis of the Β-amyloid imaging radiotracer N-methyl-[11C]2-(4'-methylaminophenyl)-6-hydroxybenzthiazole ([11C]-6-OH-BTA-1). J. Label. Compd. Radiopharm. 2004, 47:679-682.
19. Zhang W., Oya S., Hung M.P., Hou C., Maier D.L., Kung H.F. F-18 polyethyleneglycol stilbenes as PET imaging agents targeting A beta aggregates in the brain. Nuc. Med. Biol. 2005, 32:799-809.